Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.
Keosys
Interview: Helen Blanco talks about innovation in oncology space
With her large experience in the pharmaceutical industry, Helen Blanco..
From Cheson 1999 to RECIL: Evolution of the Response Assessment Criteria in Lymphoma
Lymphoma can be defined as a type of cancer that affects the lymphatic system,..
Keosys
Interview: 2022 in Review with Oana Popa-Nita
2022 Year in Review 2022 is coming to a close, and it’s a great time to reflect..
Keosys
The Best Keosys Blogs of 2022
Recap: Top blog posts of 2022 It’s been a great year for Keosys, the..
Keosys
Evaluating Tumor Response
This is an excerpt from our free eBook, “Prostate Cancer and Imaging in..
Keosys
Prostate Cancer and Imaging
This is an excerpt from our free eBook, “Prostate Cancer and Imaging in..
Keosys
Prostate Cancer Working Group 3: Imaging Assessments Infographic
Prostate Cancer Working Group 3 (PCWG3) is an international working group of..
Keosys
Interview: A Medical Doctor Finds Her Biotech Home
We recently spoke with Eveline Boucher, MD, Senior Medical Director for Boston..
Imaging and the Treatment of Prostate Cancer: A Productive Relationship
First described in 1853, prostate cancer was originally thought to be rare...
Lymphoma: The Role of Imaging in Diagnosis, Treatment, and Monitoring
Historically, computed tomography (CT) has been the main imaging modality used..
Neuroendocrine Tumors: Where Diagnosis and Treatment Meet
Neuroendocrine tumors (NETs) arise from hormone-producing cells that form part..

More Posts

New call-to-action